A Complementary Scale of Biased Agonism for Agonists With Differing Maximal Responses

Scientific Reports - United Kingdom
doi 10.1038/s41598-017-15258-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A Pharmacological Primer of Biased Agonism

Endocrine, Metabolic and Immune Disorders - Drug Targets
EndocrinologyAllergyImmunologyMetabolismDiabetes
2011English

Stepwise Autophosphorylation Regulates Biased Agonism of the Insulin Receptor

2019English

Biased Agonism: An Emerging Paradigm in GPCR Drug Discovery

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2016English

Exploring Biased Agonism at FPR1 as a Means to Encode Danger Sensing

Cells
2020English

Biased Agonism in Drug Discovery - Is It Too Soon to Choose a Path?

Molecular Pharmacology
Molecular MedicinePharmacology
2018English

Discovery of G Protein-Biased EP2 Receptor Agonists

English

Partial Agonists for Α4β2 Nicotinic Receptors Stimulate Dopaminergic Neuron Firing With Relatively Enhanced Maximal Effects

British Journal of Pharmacology
Pharmacology
2012English

Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2016English

Correction to “A Scale of Agonism and Allosteric Modulation for Assessment of Selectivity, Bias, and Receptor Mutation”

Molecular Pharmacology
Molecular MedicinePharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy